BACKGROUND: The highest mortality and morbidity worldwide is associated with atherosclerotic cardiovascular disease (ASCVD), which has in background both environmental and genetic risk factors. Apolipoprotein L1 (APOL1) variability influences the risk of ASCVD in Africans, but little is known about the APOL1 and ASCVD in other ethnic groups. METHODS: To investigate the role of APOL1 and ASCVD, we have genotyped four (rs13056427, rs136147, rs10854688 and rs9610473) APOL1 polymorphisms in a group of 1541 male patients with acute coronary syndrome (ACS) and 1338 male controls. RESULTS: Individual APOL1 polymorphisms were not associated with traditional CVD risk factors such as smoking, hypertension or diabetes prevalence, with BMI values or plasma lipid levels. Neither individual polymorphisms nor haplotypes were associated with an increased risk of ACS nor did they predict total or cardiovascular mortality over the 10.2 ± 3.9 years of follow-up. CONCLUSIONS: We conclude that APOL1 genetic variability has no major effect on risk of ACS in Caucasians.

3rd Department of Internal Medicine 1st Faculty of Medicine Charles University Prague Czech Republic

Cardiology Department Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Informatics Institute for Clinical and Experimental Medicine Prague Czech Republic

Experimental Medicine Centre Institute for Clinical and Experimental Medicine Prague Czech Republic

Preventive Cardiology Centre Institute for Clinical and Experimental Medicine Prague Czech Republic

Zobrazit více v PubMed

Cífková, R. , Skodová, Z. , Bruthans, J. , Adámková, V. , Jozífová, M. , Galovcová, M. , Wohlfahrt, P. , Krajcoviechová, A. , Poledne, R. , Stávek, P. , & Lánská, V. (2010). Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech Post‐MONICA. Atherosclerosis, 211, 676–681. PubMed

Cooper, A. , Capewell, P. , Clucas, C. , Veitch, N. , Weir, W. , Thomson, R. , Raper, J. , & MacLeod, A. (2016). A primate APOL1 variant that kills Trypanosoma brucei gambiense. PLoS Neglected Tropical Diseases, 10, e0004903. PubMed PMC

Cubedo, J. , Padró, T. , Alonso, R. , Mata, P. , & Badimon, L. (2016). ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia. Journal of Lipid Research, 57, 1059–1073. PubMed PMC

Duchateau, P. N. , Movsesyan, I. , Yamashita, S. , Sakai, N. , Hirano, K. I. , Schoenhaus, S. A. , O'Connor‐Kearns, P. M. , Spencer, S. J. , Jaffe, R. B. , Redberg, R. F. , Ishida, B. Y. , Matsuzawa, Y. , Kane, J. P. , & Malloy, M. J. (2000). Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. Journal of Lipid Research, 41, 1231–1236. PubMed

Duchateau, P. N. , Pullinger, C. R. , Cho, M. H. , Eng, C. , & Kane, J. P. (2001). Apolipoprotein L gene family: Tissue‐specific expression, splicing, promoter regions; discovery of a new gene. Journal of Lipid Research, 42, 620–630. PubMed

Estrella, M. M. , & Parekh, R. S. (2017). The expanding role of APOL1 risk in chronic kidney disease and cardiovascular isease. Seminars in Nephrology, 37, 520–529. PubMed

Friedman, D. J. (2017). A brief history of APOL1: A gene evolving. Seminars in Nephrology, 37, 508–513. PubMed

Hubacek, J. A. , Hruba, P. , Adamkova, V. , Pokorna, E. , & Viklicky, O. (2022). Apolipoprotein L1 variability is associated with increased risk of renal failure in the Czech population. Gene, 818, 146248. PubMed

Hubacek, J. A. , Staněk, V. , Gebauerová, M. , Pilipčincová, A. , Dlouhá, D. , Poledne, R. , Aschermann, M. , Skalická, H. , Matoušková, J. , Kruger, A. , Pěnička, M. , Hrabáková, H. , Veselka, J. , Hájek, P. , Lánská, V. , Adámková, V. , & Piťha, J. (2010). A FTO variant and risk of acute coronary syndrome. Clinica Chimica Acta, 411, 1069–1072. PubMed

Hubacek, J. A. , Staněk, V. , Gebauerová, M. , Poledne, R. , Aschermann, M. , Skalická, H. , Matoušková, J. , Kruger, A. , Pěnička, M. , Hrabáková, H. , Veselka, J. , Hájek, P. , Lánská, V. , Adámková, V. , & Piťha, J. (2015). Rs6922269 marker at the MTHFD1L gene predict cardiovascular mortality in males after acute coronary syndrome. Molecular Biology Reports, 42, 1289–1293. PubMed

Hubacek, J. A. , Vrablik, M. , Dlouha, D. , Stanek, V. , Gebauerova, M. , Adamkova, V. , Ceska, R. , Dostálová, G. , Linhart, A. , Vitek, L. , & Pitha, J. (2016). Gene variants at FTO, 9p21, and 2q36.3 are age‐independently associated with myocardial infarction in Czech men. Clinica Chimica Acta, 454, 119–123. PubMed

Kessler, T. , & Schunkert, H. (2021). Coronary artery disease genetics enlightened by genome‐wide association studies. JACC. Basic to Translational Science, 6, 610–623. PubMed PMC

Miller, S. A. , Dykes, D. D. , & Polesky, H. F. (1988). A simple salting out procedure for DNA extraction from human nucleated cells. Nucleic Acids Research, 16, 1215. PubMed PMC

Monajemi, H. , Fontijn, R. D. , Pannekoek, H. , & Horrevoets, A. J. (2002). The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics, 79, 539–546. PubMed

Nadkarni, G. N. , Fei, K. , Galarneau, G. , Gao, Y. , Wilson, J. G. , Cooper, R. , Madden, E. B. , Denny, J. C. , Richardson, L. D. , Pollak, M. , Loos, R. J. F. , & Horowitz, C. R. (2021). APOL1 renal risk variants are associated with obesity and body composition in African ancestry adults: An observational genotype‐phenotype association study. Medicine (Baltimore), 100, e27785. PubMed PMC

Nadkarni, G. N. , Galarneau, G. , Ellis, S. B. , Nadukuru, R. , Zhang, J. , Scott, S. A. , Schurmann, C. , Li, R. , Rasmussen‐Torvik, L. J. , Kho, A. N. , Hayes, M. G. , Pacheco, J. A. , Manolio, T. A. , Chisholm, R. L. , Roden, D. M. , Denny, J. C. , Kenny, E. E. , & Bottinger, E. P. (2017). Apolipoprotein L1 variants and blood pressure traits in African Americans. Journal of the American College of Cardiology, 69, 1564–1574. PubMed PMC

Nikpay, M. , Goel, A. , Won, H. H. , Hall, L. M. , Willenborg, C. , Kanoni, S. , Saleheen, D. , Kyriakou, T. , Nelson, C. P. , Hopewell, J. C. , Webb, T. R. , Zeng, L. , Dehghan, A. , Alver, M. , Armasu, S. M. , Auro, K. , Bjonnes, A. , Chasman, D. I. , Chen, S. , … Farrall, M. (2015). A comprehensive 1,000 genomes‐based genome‐wide association meta‐analysis of coronary artery disease. Nature Genetics, 47, 1121–1130. PubMed PMC

Page, N. M. , Butlin, D. J. , Lomthaisong, K. , & Lowry, P. J. (2001). The human apolipoprotein L gene cluster: Identification, classification, and sites of distribution. Genomics, 74, 71–78. PubMed

Palomaki, G. E. , Melillo, S. , & Bradley, L. A. (2010). Association between 9p21 genomic markers and heart disease: A meta‐analysis. JAMA, 303, 648–656. PubMed

Pays, E. , & Vanhollebeke, B. (2009). Human innate immunity against African trypanosomes. Current Opinion in Immunology, 21, 493–498. PubMed

Peng, T. , Wang, L. , & Li, G. (2017). The analysis of APOL1 genetic variation and haplotype diversity provided by 1000 genomes project. BMC Nephrology, 18, 267. PubMed PMC

Ryu, J. H. , Ge, M. , Merscher, S. , Rosenberg, A. Z. , Desante, M. , Roshanravan, H. , Okamoto, K. , Shin, M. K. , Hoek, M. , Fornoni, A. , & Kopp, J. B. (2019). APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice. PLoS One, 14, e0211559. PubMed PMC

Shin, H. J. , & McCullough, P. A. (2014). Focus on lipids: High‐density lipoprotein cholesterol and its associated lipoproteins in cardiac and renal disease. Nephron. Clinical Practice, 127, 158–164. PubMed

Staněk, V. , Gebauerová, M. , Piťha, J. , Poledne, R. , Lánská, V. , Cífková, R. , Mrázková, J. , & Kettner, J. (2017). Risk profile of patients with acute coronary syndrome treated in IKEM in 2006‐2013. Cor et Vasa, 59, e119–e127.

Thomson, R. , & Finkelstein, A. (2015). Human trypanolytic factor APOL1 forms pH‐gated cation‐selective channels in planar lipid bilayers: Relevance to trypanosome lysis. Proceedings of the National Academy of Sciences, 112, 2894–2899. PubMed PMC

Tunstall‐Pedoe, H. (Ed.). (2003). MONICA monograph and multimedia sourcebook. World Health Organisation.

Vanhamme, L. , Paturiaux‐Hanocq, F. , Poelvoorde, P. , Nolan, D. P. , Lins, L. , van den Abbeele, J. , Pays, A. , Tebabi, P. , van Xong, H. , Jacquet, A. , Moguilevsky, N. , Dieu, M. , Kane, J. P. , de Baetselier, P. , Brasseur, R. , & Pays, E. (2003). Apolipoprotein L‐I is the trypanosome lytic factor of human serum. Nature, 422, 83–87. PubMed

Vanhollebeke, B. , & Pays, E. (2006). The function of apolipoproteins L. Cellular and Molecular Life Sciences, 63, 1937–1944. PubMed PMC

Vrablik, M. , Dlouha, D. , Todorovova, V. , Stefler, D. , & Hubacek, J. A. (2021). Genetics of cardiovascular disease: How far are we from personalized CVD risk prediction and management? International Journal of Molecular Sciences, 22, 4182. PubMed PMC

Vrablik, M. , Tichý, L. , Freiberger, T. , Blaha, V. , Satny, M. , & Hubacek, J. A. (2020). Genetics of familial hypercholesterolemia: New insights. Frontiers in Genetics, 11, 574474. PubMed PMC

Young, B. A. , Fullerton, S. M. , Wilson, J. G. , Cavanaugh, K. , Blacksher, E. , Spigner, C. , Himmelfarb, J. , & Burke, W. (2017). Clinical genetic testing for APOL1: Are we there yet? Seminars in Nephrology, 37, 552–557. PubMed PMC